Author Archives: Paul Older

Prognostic values of exercise echocardiography and cardiopulmonary exercise testing in patients with primary mitral regurgitation.

Coisne A; Aghezzaf S; Galli E; Mouton S; Richardson M; Dubois D; Delsart P; Domanski O; Bauters C; Charton M; L’Official G; Modine T; Vincentelli A; Juthier F; Lancellotti P; Donal E; Montaigne D;

European heart journal. Cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2021 Nov 09.
Date of Electronic Publication: 2021 Nov 09.

Aims: To compare the clinical significance of exercise echocardiography (ExE) and cardiopulmonary exercise testing (CPX) in patients with ≥moderate primary mitral regurgitation (MR) and discrepancy between symptoms and MR severity.
Methods and Results: Patients consulting for ≥moderate discordant primary MR prospectively underwent low (25 W) ExE, peak ExE, and CPX within 2 months in Lille and Rennes University Hospital. Patients with Class I recommendation for surgical MR correction were excluded. Changes in MR severity, systolic pulmonary artery pressure (SPAP), left ventricular ejection fraction (LVEF), and tricuspid annular plane systolic excursion were evaluated during ExE. Patients were followed for major events (ME): cardiovascular death, acute heart failure, or mitral valve surgery. Among 128 patients included, 22 presented mild-to-moderate, 61 moderate-to-severe, and 45 severe MR. Unlike MR variation, SPAP and LVEF were successfully assessed during ExE in most patients. Forty-one patients (32%) displayed reduced aerobic capacity (peak VO2 < 80% of predicted value) with cardiac limitation in 28 (68%) and muscular or respiratory limitation in the 13 others (32%). ME occurred in 61 patients (47.7%) during a mean follow-up of 27 ± 21 months. Twenty-five Watts SPAP [hazard ratio (HR) (95% confidence interval, CI) = 1.03 (1.01-1.06), P = 0.003] and reduced aerobic capacity [HR (95% CI) = 1.74 (1.03-2.95), P = 0.04] were independently predictive of ME, even after adjustment for MR severity. The cut-off of 55 mmHg for 25 W SPAP showed the best accuracy to predict ME (area under the curve = 0.60, P = 0.05).
Conclusion: In patients with ≥moderate primary MR and discordant symptoms, 25 W exercise pulmonary hypertension, defined as an SPAP ≥55 mmHg, and poor aerobic capacity during CPX are independently associated with adverse events.

Reference Standards for Cardiorespiratory Fitness by Cardiovascular Disease Category and Testing Modality: Data From FRIEND.

Peterman JE; Arena R; Myers J; Marzolini S; Ades PA; Savage PD; Lavie CJ; Kaminsky LA;

Journal of the American Heart Association [J Am Heart Assoc] 2021 Nov 16; Vol. 10 (22), pp. e022336.
Date of Electronic Publication: 2021 Nov 08.

Background The importance of cardiorespiratory fitness for stratifying risk and guiding clinical decisions in patients with cardiovascular disease is well-established. To optimize the clinical value of cardiorespiratory fitness, normative reference standards are essential. The purpose of this report is to extend previous cardiorespiratory fitness normative standards by providing updated cardiorespiratory fitness reference standards according to cardiovascular disease category and testing modality.
Methods and Results The analysis included 15 045 tests (8079 treadmill, 6966 cycle) from FRIEND (Fitness Registry and the Importance of Exercise National Database). Using data from tests conducted January 1, 1974, through March 1, 2021, percentiles of directly measured peak oxygen consumption (VO 2peak ) were determined for each decade from 30 through 89 years of age for men and women with a diagnosis of coronary artery bypass surgery, myocardial infarction, percutaneous coronary intervention, or heart failure. There were significant differences between sex and age groups for VO 2peak ( P <0.001). The mean VO 2peak was 23% higher for men compared with women and VO 2peak decreased by a mean of 7% per decade for both sexes. Among each decade, the mean VO 2peak from treadmill tests was 21% higher than the VO 2peak from cycle tests. Differences in VO 2peak were observed among the age groups in both sexes according to cardiovascular disease category.
Conclusions This report provides normative reference standards by cardiovascular disease category for both men and women performing cardiopulmonary exercise testing on a treadmill or cycle ergometer. These updated and enhanced reference standards can assist with patient risk stratification and guide clinical care.

Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study.

Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Casaer MP, Gunst J, Wauters J, Wouters PJ, Goetschalckx K, Gosselink R, Van den Berghe G, Hermans G.

Intensive Care Med. 2021 Nov 8:1-10. doi: 10.1007/s00134-021-06541-9. Online ahead of print.

PURPOSE: To evaluate aerobic exercise capacity in 5-year intensive care unit (ICU) survivors and to assess the association between severity of organ failure in ICU and exercise capacity up to 5-year follow-up.
METHODS: Secondary analysis of the EPaNIC follow-up cohort (NCT00512122) including 433 patients screened with cardiopulmonary exercise testing (CPET) between 1 and 5 years following ICU admission. Exercise capacity in 5-year ICU survivors (N = 361) was referenced to a historic sedentary population and further compared to demographically matched controls (N = 49). In 5-year ICU survivors performing a maximal CPET (respiratory exchange ratio > 1.05, N = 313), abnormal exercise capacity was defined as peak oxygen consumption (VO2peak) < 85% of predicted peak oxygen consumption (%predVO2peak), based on the historic sedentary population. Exercise liming factors were identified. To study the association between severity of organ failure, quantified as the maximal Sequential Organ Failure Assessment score during ICU-stay (SOFA-max), and exercise capacity as assessed with VO2peak, a linear mixed model was built, adjusting for predefined confounders and including all follow-up CPET studies. RESULTS: Exercise capacity was abnormal in 118/313 (37.7%) 5-year survivors versus 1/48 (2.1%) controls with a maximal CPET, p < 0.001. Aerobic exercise capacity was lower in 5-year survivors than in controls (VO2peak: 24.0 ± 9.7 ml/min/kg versus 31.7 ± 8.4 ml/min/kg, p < 0.001; %predVO2peak: 94% ± 31% versus 123% ± 25%, p < 0.001). Muscular limitation frequently contributed to impaired exercise capacity at 5-year [71/118 (60.2%)]. SOFA-max independently associated with VO2peak throughout follow-up.
CONCLUSIONS: Critical illness survivors often display abnormal aerobic exercise capacity, frequently involving muscular limitation. Severity of organ failure throughout the ICU stay independently associates with these impairments.

Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection

Malcolm A West FRCS, PhD, William CA Baker BMBS, Saqib Rahman MRCS, Alicia Munro BMBS, Sandy Jack PhD, Michael PW Grocott MD, FRCA, Timothy J Underwood FRCS, PhD, Denny ZH Levett FRCA, PhD, For the Fit-4-Surgery Consortium

Journal of Surgical Oncology; 31 August 2021
https://doi.org/10.1002/jso.26652

Background
Sarcopenia (low skeletal muscle mass), myosteatosis (low skeletal muscle radiation-attenuation) and fitness are independently associated with postoperative outcomes in oesophago-gastric cancer. This study aimed to investigate (1) the effect of neoadjuvant therapy (NAT) on sarcopenia, myosteatosis and cardiopulmonary exercise testing (CPET), (2) the relationship between these parameters, and (3) their association with postoperative morbidity and survival.
Methods
Body composition analysis used single slice computed tomography (CT) images from chest (superior to aortic arch) and abdominal CT scans (third lumbar vertebrae). Oxygen uptake at anaerobic threshold (VO2 at AT) and at peak exercise (VO2 Peak) were measured using CPET. Measurements were performed before and after NAT and an adjusted regression model assessed their association.
 Results
Of the 184 patients recruited, 100 underwent surgical resection. Following NAT skeletal muscle mass, radiation-attenuation and fitness reduced significantly (p < 0.001). When adjusted for age, sex, and body mass index, only pectoralis muscle mass was associated with VO2 Peak (p = 0.001). VO2 at AT and Peak were associated with 1-year survival, while neither sarcopenia nor myosteatosis were associated with morbidity or survival.
Conclusion
Skeletal muscle and CPET variables reduced following NAT and were positively associated with each other. Cardiorespiratory function significantly contributes to short-term survival after oesophago-gastric cancer surgery.

Heart Rate Variability and Its Associations with Organ Complications in Adults after Fontan Operation.

Okólska M; Łach J; Matusik PT; Pająk J;Mroczek T; Podolec P; Tomkiewicz-Pająk L;

Journal of clinical medicine [J Clin Med] 2021 Sep 29; Vol. 10 (19).
Date of Electronic Publication: 2021 Sep 29.

Reduction of heart rate variability (HRV) parameters may be a risk factor and precede the occurrence of arrhythmias or the development of heart failure and complications in people with postinfarct left ventricular dysfunction and after coronary artery bypass grafting. Data on this issue in adults after a Fontan operation (FO) are scarce. This study assessed the association between HRV, exercise capacity, and multiorgan complications in adults after FO. Data were obtained from 30 FO patients (mean age 24 ± 5.4 years) and 30 healthy controls matched for age and sex. HRV was investigated in all patients by clinical examination, laboratory tests, echocardiography, a cardiopulmonary exercise test, and 24-h electrocardiogram. The HRV parameters were reduced in the FO group. Reduced HRV parameters were associated with patients’ age at the time of FO, time since surgery, impaired exercise capacity, chronotropic incompetence parameters, and multiorgan complications. Univariate analysis showed that saturated O 2 at rest, percentage difference between adjacent NN intervals of >50 ms duration, and peak heart rate were associated with chronotropic index. Multivariable analysis revealed that all three variables were independent predictors of the chronotropic index. The results of this study suggest novel pathophysiological mechanisms that link HRV, physical performance, and organ damage in patients after FO.

COVID-19: the new cause of dyspnoea as a result of reduced lung and peripheral muscle performance.

Acar RD; Sarıbaş E; Güney PA; Kafkas Ç; Aydınlı D; Taşçı E; Kırali MK;

Journal of breath research [J Breath Res] 2021 Oct 04; Vol. 15 (4).
Date of Electronic Publication: 2021 Oct 04.

This study aimed to evaluate the cardiopulmonary function and impairment of exercise endurance in patients with COVID-19 after 3 months of the second wave of the pandemic in Turkey. A total of 51 consecutive COVID-19 survivors, mostly healthcare providers, still working in the emergency room and intensive care units of the hospital after the second wave of Covid 19 pandemia were included in this study. Cardiopulmonary exercise stress test was performed. The median of the exercise time of the COVID-19 survivors, was 10 (4.5-13) minutes and the mean 6.8 ± 1.3 Mets was achieved. The VO 2 max of the COVID-19 survivors was 24 ± 4.6 ml kg -1 min -1 which corresponds the 85 ± 10% of the predicted VO 2 max value. The VO 2 WRs value which was reported about 8.5-11 ml min -1 per watt in healthy individuals as normal was found lower in Covid 19 survivors (5.6 ± 1.4). The percentage of the maximum peak VO 2 calculated according to the predictable peak VO 2 of the COVID-19 survivors, was found significantly lower in male patients (92 ± 9.5% vs 80 ± 8.5%, p : 0.000). Also, there was a positive correlation between the percentage of the maximum predicted VO 2 measurements and age ( r : 0.320, p : 0000). The peak VO 2 values of COVID-19 survivors decreased, and simultaneously, their exercise performance decreased due to peripheral muscle involvement. We believe that COVID-19 significantly affects men and young patients.

Differences in Peak Oxygen Uptake in Bicycle Exercise Test Caused by Body Positions: A Meta-Analysis.

Wan X; Liu C; Olson TP;Chen X; Lu W; Jiang W;

Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2021 Oct 11; Vol. 8, pp. 734687.
Date of Electronic Publication: 2021 Oct 11 (Print Publication: 2021).

Background: As demand for cardiopulmonary exercise test using a supine position has increased, so have the testing options. However, it remains uncertain whether the existing evaluation criteria for the upright position are suitable for the supine position. The purpose of this meta-analysis is to compare the differences in peak oxygen uptake (VO 2peak ) between upright and supine lower extremity bicycle exercise.
Methods: We searched PubMed, Web Of Science and Embase from inception to March 27, 2021. Self-control studies comparing VO 2peak between upright and supine were included. The quality of the included studies was assessed using a checklist adapted from published papers in this field. The effect of posture on VO 2peak was pooled using random/fixed effects model.
Results: This meta-analysis included 32 self-control studies, involving 546 participants (63% were male). 21 studies included only healthy people, 9 studies included patients with cardiopulmonary disease, and 2 studies included both the healthy and cardiopulmonary patients. In terms of study quality, most of the studies ( n = 21, 66%) describe the exercise protocol, and we judged theVO 2peak to be valid in 26 (81%) studies. Meta-analysis showed that the upright VO 2peak exceeded the supine VO 2peak [relative VO 2peak : mean difference (MD) 2.63 ml/kg/min, 95% confidence interval (CI) 1.66-3.59, I2 = 56%, p < 0.05; absolute VO 2peak : MD 0.18 L/min, 95% CI 0.10-0.26, I2 = 63%, p < 0.05). Moreover, subgroup analysis showed there was more pooled difference in healthy people (4.04 ml/kg/min or 0.22 L/min) than in cardiopulmonary patients (1.03 ml/kg/min or 0.12 L/min).
Conclusion: VO 2peak in the upright position is higher than that in supine position. However, whether this difference has clinical significance needs further verification.

Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial.

Allen SK; Brown V;White D; King D; Hunt J; Wainwright J; Emery A; Hodge E; Kehinde A; Prabhu P; Rockall TA; Preston SR; Sultan J;

Annals of surgical oncology [Ann Surg Oncol] 2021 Nov 01.
Date of Electronic Publication: 2021 Nov 01.

Background: Neoadjuvant therapy reduces fitness, muscle mass, and quality of life (QOL). For patients undergoing chemotherapy and surgery for esophagogastric cancer, maintenance of fitness is paramount. This study investigated the effect of exercise and psychological prehabilitation on anaerobic threshold (AT) at cardiopulmonary exercise testing (CPET). Secondary endpoints included peak oxygen uptake (peak VO 2 ), skeletal muscle mass, QOL, and neoadjuvant therapy completion.
Methods: This parallel-arm randomized controlled trial assigned patients with locally advanced esophagogastric cancer to receive prehabilitation or usual care. The 15-week program comprised twice-weekly supervised exercises, thrice-weekly home exercises, and psychological coaching. CPET was performed at baseline, 2 weeks after neoadjuvant therapy, and 1 week preoperatively. Skeletal muscle cross-sectional area at L3 was analyzed on staging and restaging computed tomography. QOL questionnaires were completed at baseline, mid-neoadjuvant therapy, at restaging laparoscopy, and postoperatively at 2 weeks, 6 weeks and 6 months.
Results: Fifty-four participants were randomized (prehabilitation group, n = 26; control group, n = 28). No difference in AT between groups was observed post-neoadjuvant therapy. Prehabilitation resulted in an attenuated peak VO 2 decline {-0.4 [95% confidence interval (CI) -0.8 to 0.1] vs. -2.5 [95% CI -2.8 to -2.2] mL/kg/min; p = 0.022}, less muscle loss [-11.6 (95% CI -14.2 to -9.0) vs. -15.6 (95% CI -18.7 to -15.4) cm 2 /m 2 ; p = 0.049], and improved QOL. More prehabilitation patients completed neoadjuvant therapy at full dose [prehabilitation group, 18 (75%) vs. control group, 13 (46%); p = 0.036]. No adverse events were reported.
Conclusions: This study has demonstrated some retention of cardiopulmonary fitness (peak VO 2 ), muscle, and QOL in prehabilitation subjects. Further large-scale trials will help determine whether these promising findings translate into improved clinical and oncological outcomes. Trial Registration ClinicalTrials.gov NCT02950324.

Prognostic value of aerobic capacity and exercise oxygen pulse in postaortic dissection patients.

Delsart P; Delahaye C; Devos P; Domanski O; Azzaoui R; Sobocinski J; Juthier F; Vincentelli A; Rousse N; Mugnier A; Soquet J; Loobuyck V; Koussa M; Modine T; Jegou B; Bical A; Hysi I; Fabre O; Pontana F; Matran R; Mounier-Vehier C; Montaigne D;

Clinical Cardiology. 44(2):252-260, 2021 Feb.

BACKGROUND: Although recommendations encourage daily moderate activities
in post aortic dissection, very little data exists regarding
cardiopulmonary exercise testing (CPET) to personalize those patient’s
physical rehabilitation and assess their cardiovascular prognosis.

DESIGN: We aimed at testing the prognostic insight of CPET regarding
aortic and cardiovascular events by exploring a prospective cohort of
patients followed-up after acute aortic dissection.

METHODS: Patients referred to our department after an acute (type A or B)
aortic dissection were prospectively included in a cohort between
September 2012 and October 2017. CPET was performed once optimal blood
pressure control was obtained. Clinical follow-up was done after CPET for
new aortic event and major cardio-vascular events (MCE) not directly
related to the aorta.

RESULTS: Among the 165 patients who underwent CPET, no adverse event was
observed during exercise testing. Peak oxygen pulse was 1.46(1.22-1.84)
mlO2/beat, that is, 97 (83-113) % of its predicted value, suggesting
cardiac exercise limitation in a population under beta blockers (92% of
the population). During a follow-up of 39(20-51) months from CPET, 42
aortic event recurrences and 22 MCE not related to aorta occurred. Low
peak oxygen pulse (<85% of predicted value) was independently predictive
of aortic event recurrence, while low peak oxygen uptake (<70% of
predicted value) was an independent predictor of MCE occurrence.

CONCLUSION: CPET is safe in postaortic dissection patients should be used
to not only to personalize exercise rehabilitation, but also to identify
those patients with the highest risk for new aortic events and MCE not
directly related to aorta.